Antibody-suppressing CD8 + T-cell Therapy for Antibody-mediated Rejection: Clinical Considerations.
Publication
, Journal Article
DeLaura, I; Anwar, IJ
Published in: Transplantation
March 2024
Duke Scholars
Published In
Transplantation
DOI
EISSN
1534-6080
ISSN
0041-1337
Publication Date
March 2024
Volume
108
Issue
3
Start / End Page
601 / 602
Related Subject Headings
- Surgery
- Mice, Inbred C57BL
- Mice
- Graft Rejection
- CD8-Positive T-Lymphocytes
- CD4-Positive T-Lymphocytes
- Antibodies
- Animals
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
DeLaura, I., & Anwar, I. J. (2024). Antibody-suppressing CD8 + T-cell Therapy for Antibody-mediated Rejection: Clinical Considerations. Transplantation, 108(3), 601–602. https://doi.org/10.1097/tp.0000000000004829
DeLaura, Isabel, and Imran J. Anwar. “Antibody-suppressing CD8 + T-cell Therapy for Antibody-mediated Rejection: Clinical Considerations.” Transplantation 108, no. 3 (March 2024): 601–2. https://doi.org/10.1097/tp.0000000000004829.
DeLaura I, Anwar IJ. Antibody-suppressing CD8 + T-cell Therapy for Antibody-mediated Rejection: Clinical Considerations. Transplantation. 2024 Mar;108(3):601–2.
DeLaura, Isabel, and Imran J. Anwar. “Antibody-suppressing CD8 + T-cell Therapy for Antibody-mediated Rejection: Clinical Considerations.” Transplantation, vol. 108, no. 3, Mar. 2024, pp. 601–02. Epmc, doi:10.1097/tp.0000000000004829.
DeLaura I, Anwar IJ. Antibody-suppressing CD8 + T-cell Therapy for Antibody-mediated Rejection: Clinical Considerations. Transplantation. 2024 Mar;108(3):601–602.
Published In
Transplantation
DOI
EISSN
1534-6080
ISSN
0041-1337
Publication Date
March 2024
Volume
108
Issue
3
Start / End Page
601 / 602
Related Subject Headings
- Surgery
- Mice, Inbred C57BL
- Mice
- Graft Rejection
- CD8-Positive T-Lymphocytes
- CD4-Positive T-Lymphocytes
- Antibodies
- Animals
- 3204 Immunology
- 3202 Clinical sciences